Cargando…
miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach
BACKGROUND AND AIMS: KRT19 was identified as one of the key biomarkers for distinguishing cholangiocarcinoma (CCA) and hepatocellular carcinoma. The detailed role of miRNAs involved in the oncogenic incident of KRT19 was poor investigated. RESULTS: Based on prediction and validation, miR-26a was inv...
Autores principales: | Wang, Ping, Lv, Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348398/ https://www.ncbi.nlm.nih.gov/pubmed/27833076 http://dx.doi.org/10.18632/oncotarget.13229 |
Ejemplares similares
-
Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma
por: Wang, Li-Juan, et al.
Publicado: (2015) -
Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer
por: Li, Yang, et al.
Publicado: (2017) -
miR-26a Suppresses Tumor Growth and Metastasis by Targeting FGF9 in Gastric Cancer
por: Deng, Min, et al.
Publicado: (2013) -
Suppression of miR-16 promotes tumor growth and metastasis through reversely regulating YAP1 in human cholangiocarcinoma
por: Han, Sheng, et al.
Publicado: (2017) -
Inhibition of miR-10a-5p suppresses cholangiocarcinoma cell growth through downregulation of Akt pathway
por: Gao, Lili, et al.
Publicado: (2018)